Development and optimization of lipoplex vectors for an
Development and optimization of lipoplex vectors for an
antisens therapeutic approach in the context of HPV induced
antisens therapeutic approach in the context of HPV induced
lesions
lesions
Contact : anna.lechanteur@student.ulg.ac.be
Anna Lechanteur1,Brigitte Evrard1,Philippe Delvenne2, Patrick Roncarat2 ,Pascale Hubert2, Geraldine Piel1 1Laboratory of Pharmaceutcal Technology-CIRM, 2Laboratory of Experimental Pathology, GIGA-CANCER
University of Liege, Liège, Belgium
HPV 16 and 18 are responsible for cervical cancers, in over 70% of cases. These viruses integrate into keratnocyte cells and induce
the expression of oncogenes E6 and E7. These prevent the expression of tumor suppressor genes (p53 and pRb) and lead
keratnocytes transformaton into tumor cells.
The purpose of this study is to target locally mRNA encoding for E6-E7 oncoproteins with siRNA. In order to protect and to
optmize their penetraton through the vaginal mucus and into the cytoplasm, siRNA will be incorporated into catonic liposomes.
HPV 16 and 18 are responsible for cervical cancers, in over 70% of cases. These viruses integrate into keratnocyte cells and induce
the expression of oncogenes E6 and E7. These prevent the expression of tumor suppressor genes (p53 and pRb) and lead
keratnocytes transformaton into tumor cells.
The purpose of this study is to target locally mRNA encoding for E6-E7 oncoproteins with siRNA. In order to protect and to
optmize their penetraton through the vaginal mucus and into the cytoplasm, siRNA will be incorporated into catonic liposomes.
Cervical cancer
Human Papillomavirus responsible for cervical cancer
Histological development of cervical cancer Development of cervical cancer
Frequently two (DOTAP and DOTMA)
Biodegradable (DOTAP = ester) Essential CATIONIC charged (but toxic)
Liposomes
Cationic lipids used: general structure
Lipid bilayer Internal aqueous compartment
Characteristics required
• High transfecton• Selectve for E6 and E7 proteins • Induce APOPTOSIS of cancer cells
Design rules
• Double strand (17-25 nucleotdes) • + 2dTdT at the 3’end of the antsens sequence • GC content less than 50%
• …
siRNA
2 sequences selected
: - siRNA targetng E6 (against HPV16) :- siRNA targetng E7 (against HPV16) :
1) Cells transfecton using
Transfectne ®
• HPV16+ : SiHa, CaSki • HPV16- : C33A • HPV18+ : C4 II2) Tests
• % transfecton (FACS)• % decrease of oncoproteins E6 and E7 (QRT-PCR)
• % apoptosis: Annexin V-PI (FACS)
5’---CUAGGCAAACAACUAUACAUGAUAdTdT---3’
3’---dTdTGAUCCGUUUGUUGAUAUGUACUAU---5’
5’---AGGAGGAUGAAAUAGAUGGdTdT---3’
3’---dTdTUCCUCCUACUUUAUCUACC---5’
Physico-chemical characterization:
Morphology, size (<200nm), zeta potental (0-40mV), physical stability over the tme, encapsulaton rate, capacity to release their content,…
Tests on cells:
• HPV16+ : SiHa, CaSki • HPV16- : C33A • HPV18+ : C4-II Tests on organotypic cultures to evaluate penetration efficiency
Validation of the concept in vivo (mice)
Tools to improve the efficiency of lipoplexes
• Add neutral lipids (DOPE, cholesterol), PEG, change proportons of compounds,…
Lipoplexes
Evaluaton of the transfecton efficiency and cytotoxicity